Literature DB >> 2819782

Cortical GABAB and GABAA receptors in Alzheimer's disease: a quantitative autoradiographic study.

D C Chu, J B Penney, A B Young.   

Abstract

GABAB and GABAA binding sites were evaluated by quantitative autoradiography of 3H-GABA binding in superior frontal gyrus of persons who died with dementia of the Alzheimer's type (DAT) and of age-matched normal controls. Scatchard analysis and competition studies disclosed 48 to 68% and 25% decrements in receptor density (Bmax) for GABAB and GABAA receptors, respectively, in layers II, III, and V of DAT frontal cortex as compared with controls. No significant difference in affinity (KD) for either GABAA or GABAB receptors was found. Our data may reflect multisystem pathologic involvement in DAT neocortex.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819782     DOI: 10.1212/wnl.37.9.1454

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  21 in total

Review 1.  Current therapeutic targets for the treatment of Alzheimer's disease.

Authors:  Joshua D Grill; Jeffrey L Cummings
Journal:  Expert Rev Neurother       Date:  2010-05       Impact factor: 4.618

Review 2.  Transmitter receptors and functional anatomy of the cerebral cortex.

Authors:  Karl Zilles; Nicola Palomero-Gallagher; Axel Schleicher
Journal:  J Anat       Date:  2004-12       Impact factor: 2.610

Review 3.  Inhibiting BACE1 to reverse synaptic dysfunctions in Alzheimer's disease.

Authors:  Riqiang Yan; Qingyuan Fan; John Zhou; Robert Vassar
Journal:  Neurosci Biobehav Rev       Date:  2016-04-01       Impact factor: 8.989

4.  The neuropharmacological restoration of cognitive functions of cats following a lesion to the basal nuclei of the forebrain (Meynert's nucleus).

Authors:  E I Mukhin; T N Nabieva
Journal:  Neurosci Behav Physiol       Date:  1993 Jul-Aug

5.  Differential alterations of cortical glutamatergic binding sites in senile dementia of the Alzheimer type.

Authors:  D T Chalmers; D Dewar; D I Graham; D N Brooks; J McCulloch
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

Review 6.  Implications for treatment: GABAA receptors in aging, Down syndrome and Alzheimer's disease.

Authors:  Robert A Rissman; William C Mobley
Journal:  J Neurochem       Date:  2011-03-28       Impact factor: 5.372

7.  SPECT imaging of GABA(A)/benzodiazepine receptors and cerebral perfusion in mild cognitive impairment.

Authors:  Sabina Pappatà; Andrea Varrone; Caterina Vicidomini; Graziella Milan; Caterina De Falco; Valeria Sansone; Alessandro Iavarone; Marco Comerci; Elisa Loré; Maria Rosaria Panico; Mario Quarantelli; Alfredo Postiglione; Marco Salvatore
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03-20       Impact factor: 9.236

8.  Influence of hippocampal GABAB receptor inhibition on memory in rats with acute β-amyloid toxicity.

Authors:  Azam Almasi; Mohammad Zarei; Safoura Raoufi; Abdolrahman Sarihi; Iraj Salehi; Alireza Komaki; Nasrin Hashemi-Firouzi; Siamak Shahidi
Journal:  Metab Brain Dis       Date:  2018-07-23       Impact factor: 3.584

9.  Distribution of GABA-containing neurons in human frontal cortex: a quantitative immunocytochemical study.

Authors:  J P Hornung; N De Tribolet
Journal:  Anat Embryol (Berl)       Date:  1994-02

Review 10.  Recent advances in geriatric psychopharmacology.

Authors:  C A Naranjo; N Herrmann; N Mittmann; K E Bremner
Journal:  Drugs Aging       Date:  1995-09       Impact factor: 3.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.